Submission regarding PMPRB's Guideline Monitoring and Evaluation Plan


Date de parution : 07/19/2021
Personne(s)-ressource(s) : Karen Voin

The Canadian Life and Health Insurance Association (CLHIA) is pleased to provide its comments to the Patented Medicine Prices Review Board (PMPRB) as part of the Consultation on the Guideline Monitoring and Evaluation Plan (GMEP).